Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_assertion type Assertion NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_head.
- NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_assertion description "[Together, our study defines NKG2D-Ls as targets for a CAR-mediated T cell based immunotherapy of ESFT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_provenance.
- NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_assertion evidence source_evidence_literature NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_provenance.
- NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_assertion SIO_000772 22355347 NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_provenance.
- NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_assertion wasDerivedFrom befree-20140225 NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_provenance.
- NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_assertion wasGeneratedBy ECO_0000203 NP649419.RAbXHSVCarOtq5fX7RkXdKCdU-PAAPq0n9GGXGu8yLNz0130_provenance.